Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Kevin T. Nead Image

      Kevin T. Nead, MD, MPhil

      Department of Epidemiology, Division of Cancer Prevention and Population Sciences

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Associate Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Member, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas

      Education & Training

      Degree-Granting Education

      2014Stanford University School of Medicine, Stanford, California, US, MD
      2012University of Cambridge, Cambridge, GB, Epidemiology, MPhil (Masters)
      2008University of Florida, Gainesville, Florida, US, Zoology, BS

      Postgraduate Training

      2015-2019Clinical Residency, Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania
      2014-2015Clinical Internship, Internal Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania

      Licenses & Certifications

      2021American Board of Radiology (Radiation Oncology)
      2019Texas Medical License

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2026

      Assistant Professor, Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2026

      Other Professional Positions

      Associate Fellow, Leonard Davis Institute of Health Economics, Philadelphia, PA, 2015 - 2019

      Honors & Awards

      2026ASTRO Annual Meeting Basic Translational Award in Biology, ASTRO
      2025Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, Nominated, The University of Texas MD Anderson Cancer Center
      2024JACC CardioOnc’s Young Author Achievement Award (Mentor), American College of Cardiology
      2024ASTRO Annual Meeting Travel Award, Biology, ASTRO
      2023Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center
      2022Educator of the Year, Association of Residents in Radiation Oncology (ARRO)
      2018Conquer Cancer Foundation of ASCO Merit Award, The American Society of Clinical Oncology Foundation
      2018Charles J. Epstein Trainee Award for Excellence in Human Genetics Research - Finalist, American Society of Human Genetics
      2016B. Leonard Holman Research Pathway, The American Board of Radiology
      2013MacKenzie Foundation Scholarship, MacKenzie Foundation
      2013Young Investigator Award - Finalist, American College of Cardiology
      2013Kaiser Permanente of Northern California Medical Student Scholarship, Kaiser Permanente
      2013Travel Grant, Society for Vascular Medicine
      2012Distinction in the MPhil thesis, examinations, and degree, University of Cambridge
      2012American Heart Association Student Scholarship in Cardiovascular Disease and Stroke, American Heart Association
      20121st in Class - GlaxoSmithKline Award, University of Cambridge
      2012Scholar-in-Training Award, American Association for Cancer Research
      2011Gates-Cambridge Scholarship, Gates-Cambridge
      2010 - 2012Medical Scholars Research Fellowship, Stanford University
      2010Medical Student Research Fellowship, American Heart Association
      2008Phi Beta Kappa, University of Florida
      2008Academic-All American; First Team, Division I, National Collegiate Athletic Association (NCAA)
      2008United States Olympic Swimming Trials Qualifier, United States Olympics
      2008Postgraduate Scholarship, National Collegiate Athletic Association (NCAA)
      2008Summa Cum Laude, University of Florida
      2007Howard Hughes Medical Institute Undergraduate Research Fellowship, University of Florida
      2005United States Swimming National Championship Finalist, USA Swimming

      Grant & Contract Support

      Date: 2025 - 2028
      Title:Metabolomic and Genetic Factors Decoupling Immune Checkpoint Inhibitor Tumor Efficacy and Cardiovascular Toxicity
      Funding Source:FDA
      Role:Co-I
      ID:U01FD008717
      Date: 2025 - 2029
      Title:Deciphering the role of GFPT2 in radiation-induced cardiovascular disease
      Funding Source:NIH/NCI
      Role:Co-I
      ID:R01HL179815
      Date: 2025 - 2032
      Title:The role of cancer in cardiovascular disease
      Funding Source:NIH/NHLBI
      Role:Co-I
      ID:R35HL176060
      Date: 2025 - 2028
      Title:Defining how cancer accelerates atherosclerosis by provoking intraplaque neovascularization
      Funding Source:American Heart Association
      Role:Mentor
      ID:25CDA1452612
      Date: 2025 - 2028
      Title:Clonal hematopoiesis and toxicity from radiation therapy
      Funding Source:CPRIT
      Role:PI
      ID:RP250062
      Date: 2024 - 2026
      Title:Characterization and Prediction of Second-Generation Anti-Androgen Associated Neurotoxicity in Patients with Prostate Cancer
      Funding Source:Cancer Neuroscience Program, MD Anderson
      Role:PI
      ID:CNP129405
      Date: 2021 - 2026
      Title:Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy
      Funding Source:NIH/NCI
      Role:PI
      ID:K08CA263313
      Date: 2021 - 2024
      Title:Risk Factors and Mechanisms of Radiation-Induced Cardiovascular Disease
      Funding Source:Multidisciplinary Research Program (MRP)
      Role:Core Leader
      ID:RCTS#00059910
      Date: 2020 - 2025
      Title:Causes and consequences of clonal hematopoiesis mutations
      Funding Source:NIH/NCI (Loan Repayment Program)
      Role:PI
      ID:L30CA253796
      Date: 2020 - 2022
      Title:Defining acquired mutations in healthy breast tissue and their association with breast cancer risk factors and breast cancer risk
      Funding Source:Duncan Family Institute
      Role:PI
      Date: 2020 - 2021
      Title:Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity
      Funding Source:Conquer Cancer Foundation of ASCO
      Role:PI
      Date: 2019 - 2022
      Title:Science and Technology Acquisition and Retention Program (STARs)
      Funding Source:University of Texas (UT)
      Role:PI
      Date: 2019 - 2025
      Title:Recruitment of First-Time, Tenure-Track Faculty Members
      Funding Source:CPRIT
      Role:PI
      ID:RR190077
      Date: 2019 - 2019
      Title:Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity
      Funding Source:Marlene Shlomchik Fellowship in Cancer Research; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine
      Role:PI
      Date: 2018 - 2019
      Title:Risk of cancer in children among families known to carry BRCA1/2 mutations
      Funding Source:The Gerber Foundation
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Torres, J, Navarro, S, Gao, H, Xiong, T, Wehner, MR, Hawk, E, Leeper, NJ, Nead, KT. American Heart Association cardiovascular health metrics and cancer outcomes. American Heart Journal 297, 2026. e-Pub 2026. PMID: 41856447.
      2. Baylis, RA, Haas, A, Gao, H, Giordano, SH, Nead, KT, Leeper, NJ. Disproportionate Risk of Cancer Following Diagnosis of Peripheral Artery Disease. JACC: Advances 5(7), 2026. e-Pub 2026. PMID: 42296840.
      3. Nead KT, Haas AM, Zhao J, Xiong T, Tang C, Giordan SH, Leeper NJ. Cardiovascular disease and diagnosis of advanced prostate cancer. Cardiooncology 11(1):85, 2025. e-Pub 2025. PMID: 41035100.
      4. Angelov I, Haas AM, Brock E, Luo L, Zhao J, Smith BD, Giordano SH, Leeper NJ, Nead KT. Cardiovascular Disease and Breast Cancer Stage at Diagnosis. JAMA Netw Open 8(1):e2452890, 2025. e-Pub 2025. PMID: 39745699.
      5. Navsaria LJ, Haas AM, Corredor JL, Arun BK, Giordano SH, Nead KT, Wehner MR. Skin cancer risk in patients with BRCA mutations. JAAD Int 17:175-177, 2024. e-Pub 2024. PMID: 39525845.
      6. Nead KT, Kim T, Joo L, McDowell T, Wong J, Chan IC, Brock E, Zhao J, Xu T, Tang C, Lee CL, Abe JI, Bolton KL, Liao Z, Scheet P, Lin SH. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Blood Adv 8(19):5215-5224, 2024. e-Pub 2024. PMID: 38830141.
      7. Luo L, Haas AM, Bell CF, Baylis RA, Adkar SS, Fu C, Angelov I, Giordano SH, Klarin D, Leeper NJ, Nead KT. Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 44(7):1694-1701, 2024. e-Pub 2024. PMID: 38779853.
      8. Bell CF, Lei X, Haas A, Baylis RA, Gao H, Luo L, Giordano SH, Wehner MR, Nead KT, Leeper NJ. Risk of Cancer After Diagnosis of Cardiovascular Disease. JACC CardioOncol 5(4):431-440, 2023. e-Pub 2023. PMID: 37614573.
      9. Nowakowska MK, Ortega RM, Wehner MR, Nead KT. Association of Second-generation Antiandrogens With Cognitive and Functional Toxic Effects in Randomized Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol 9(7):930-937, 2023. e-Pub 2023. PMID: 37227736.
      10. Nead KT, Hinkston CL, Wehner M. Cautions When Using Race and Ethnicity in Administrative Claims Data Sets. JAMA Health Forum 3(7), 2022. e-Pub 2022. PMID: 36218996.
      11. Carey RM, Kim T, Cohen NA, Lee RJ, Nead KT. Impact of sweet, umami, and bitter taste receptor (TAS1R and TAS2R) genomic and expression alterations in solid tumors on survival. Sci Rep 12(1):8937, 2022. e-Pub 2022. PMID: 35624283.
      12. Nowakowska MK, Kim T, Thompson MT, Bolton KL, Deswal A, Lin SH, Scheet P, Wehner MR, Nead KT. Association of clonal hematopoiesis mutations with clinical outcomes: a systematic review and meta-analysis. Am J Hematol 97(4):411-420, 2022. e-Pub 2022. PMID: 35015316.
      13. Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH, Nead KT. Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US. JAMA Netw Open 5(2):e2148021, 2022. e-Pub 2022. PMID: 35147686.
      14. Nowakowska MK, Lei X, Wehner MR, Corn PG, Giordano SH, Nead KT. Association of Second-generation Antiandrogens with Depression Among Patients With Prostate Cancer. JAMA Netw Open 4(12):e2140803, 2021. e-Pub 2021. PMID: 34940861.
      15. Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH, Nead KT. Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127(22):4142-4150, 2021. e-Pub 2021. PMID: 34342892.
      16. Nead KT, Hinkston CL, Linos E, Giordano SH, Wehner MR. American Board of Medical Specialties Board Examination Lactation Accommodation Policies. JAMA Intern Med 181(10):1397-1399, 2021. e-Pub 2021. PMID: 34180945.
      17. Arscott WT, Nead KT, Bear A, Venigalla S, Shabason J, Lukens JN, Plastaras JP, Wojcieszynski A, Metz J, O'Hara M, Reiss KA, Teitelbaum U, Loaiza-Bonilla A, Drebin J, Lee MK, Shroff SG, Ben-Josef E. Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. Am J Clin Oncol 44(9):469-474, 2021. e-Pub 2021. PMID: 34310350.
      18. Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open 4(4):e214708, 2021. e-Pub 2021. PMID: 33825840.
      19. Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT. Association of Endocrine Therapy and Dementia in Women with Breast Cancer. Breast Cancer (Dove Med Press) 13:219-224, 2021. e-Pub 2021. PMID: 33854369.
      20. Wehner MR, Li Y, Nead KT. Comparison of the Proportions of Female and Male Corresponding Authors in Preprint Research Repositories Before and During the COVID-19 Pandemic. JAMA Netw Open 3(9):e2020335, 2020. e-Pub 2020. PMID: 32940678.
      21. Nead KT, Mitra N, Weathers B, Pyle L, Emechebe N, Pucci DA, Jacobs LA, Vaughn DJ, Nathanson KL, Kanetsky PA. Lower abdominal and pelvic radiation and testicular germ cell tumor risk. PLoS One 15(11):e0239321, 2020. e-Pub 2020. PMID: 33175879.
      22. Nead KT, Swisher-McClure S. Utilization of hypofractionated radiation therapy in older glioblastoma patients. J Geriatr Oncol 10(1):155-158, 2019. e-Pub 2019. PMID: 30017732.
      23. Nead KT, Wehner MR, Mitra N. The Use of "Trend" Statements to Describe Statistically Nonsignificant Results in the Oncology Literature. JAMA Oncol 4(12):1778-1779, 2018. e-Pub 2018. PMID: 30347042.
      24. Nead KT, Boldbaatar N, Yang DD, Sinha S, Nguyen PL. Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis. Urology 114:155-162, 2018. e-Pub 2018. PMID: 29352986.
      25. Venigalla S, Nead KT, Sebro R, Guttmann DM, Sharma S, Simone CB, Levin WP, Wilson RJ, Weber KL, Shabason JE. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys 100(4):1004-1015, 2018. e-Pub 2018. PMID: 29485042.
      26. Nead KT, Sinha S, Yang DD, Nguyen PL. Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis. Urol Oncol 35(11):664.e1-664.e9, 2017. e-Pub 2017. PMID: 28803700.
      27. Nead KT, Sinha S, Nguyen PL. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 20(3):259-264, 2017. e-Pub 2017. PMID: 28349979.
      28. Wehner MR, Nead KT, Linos E. Correlation Among Cancer Incidence and Mortality Rates and Internet Searches in the United States. JAMA Dermatol 153(9):911-914, 2017. e-Pub 2017. PMID: 28658470.
      29. Wehner MR, Nead KT, Lipoff JB. Association Between Gender and Drug Cost for Over-the-Counter Minoxidil. JAMA Dermatol 153(8):825-826, 2017. e-Pub 2017. PMID: 28593214.
      30. Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association Between Androgen Deprivation Therapy and Risk of Dementia. JAMA Oncol 3(1):49-55, 2017. e-Pub 2017. PMID: 27737437.
      31. Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley JT, Leeper NJ, Shah NH. Influence of age on androgen deprivation therapy-associated Alzheimer's disease. Sci Rep 6:35695, 2016. e-Pub 2016. PMID: 27752112.
      32. Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley JT, Leeper NJ, Shah NH. Androgen Deprivation Therapy and Future Alzheimer's Disease Risk. J Clin Oncol 34(6):566-71, 2016. e-Pub 2016. PMID: 26644522.
      33. Wehner MR, Nead KT, Linos K, Linos E. Plenty of moustaches but not enough women: cross sectional study of medical leaders. BMJ 351:h6311, 2015. e-Pub 2015. PMID: 26673637.
      34. Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A, Group (ANECS) ANECS, Perry JR, Attia J, Dunning AM, Easton DF, Holliday E, Lotta LA, O'Mara T, McEvoy M, Pharoah PD, Scott RJ, Spurdle AB, Langenberg C, Wareham NJ, Scott RA. Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst 107(9), 2015. e-Pub 2015. PMID: 26134033.
      35. Nead KT, Li A, Wehner MR, Neupane B, Gustafsson S, Butterworth A, Engert JC, Davis AD, Hegele RA, Miller R, den Hoed M, Khaw KT, Kilpeläinen TO, Wareham N, Edwards TL, Hallmans G, Varga TV, Kardia SL, Smith JA, Zhao W, Faul JD, Weir D, Mi J, Xi B, Quinteros SC, Cooper C, Sayer AA, Jameson K, Grøntved A, Fornage M, Sidney S, Hanis CL, Highland HM, Häring HU, Heni M, Lasky-Su J, Weiss ST, Gerhard GS, Still C, Melka MM, Pausova Z, Paus T, Grant SF, Hakonarson H, Price RA, Wang K, Scherag A, Hebebrand J, Hinney A, Japan B, AGEN-BMI, Consortium G, Franks PW, Frayling TM, McCarthy MI, Hirschhorn JN, Loos RJ, Ingelsson E, Gerstein HC, Yusuf S, Beyene J, Anand SS, Meyre D. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Hum Mol Genet 24(12):3582-94, 2015. e-Pub 2015. PMID: 25784503.
      36. Myers J, Nead KT, Chang P, Abella J, Kokkinos P, Leeper NJ. Improved reclassification of mortality risk by assessment of physical activity in patients referred for exercise testing. Am J Med 128(4):396-402, 2015. e-Pub 2015. PMID: 25511076.
      37. Chang P, Nead KT, Olin JW, Myers J, Cooke JP, Leeper NJ. Effect of physical activity assessment on prognostication for peripheral artery disease and mortality. Mayo Clin Proc 90(3):339-45, 2015. e-Pub 2015. PMID: 25649965.
      38. Chang P, Nead KT, Olin JW, Cooke JP, Leeper NJ. Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med 19(4):289-296, 2014. e-Pub 2014. PMID: 24872403.
      39. Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 42(3):610-8, 2014. e-Pub 2014. PMID: 24481828.
      40. Downing KP, Nead KT, Kojima Y, Assimes T, Maegdefessel L, Quertermous T, Cooke JP, Leeper NJ. The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model. Vasc Med 19(1):3-8, 2014. e-Pub 2014. PMID: 24323119.
      41. Priest JR, Nead KT, Wehner MR, Cooke JP, Leeper NJ. Self-reported history of childhood smoking is associated with an increased risk for peripheral arterial disease independent of lifetime smoking burden. PLoS One 9(2):e88972, 2014. e-Pub 2014. PMID: 24558458.
      42. Nead KT, Cooke JP, Olin JW, Leeper NJ. Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol 62(6):553-9, 2013. e-Pub 2013. PMID: 23707317.
      43. Nead KT, Zhou M, Diaz Caceres R, Olin JW, Cooke JP, Leeper NJ. Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status. Circ Cardiovasc Qual Outcomes 6(3):255-61, 2013. e-Pub 2013. PMID: 23633217.
      44. Nead KT, Zhou MJ, Caceres RD, Sharp SJ, Wehner MR, Olin JW, Cooke JP, Leeper NJ. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol 111(6):851-6, 2013. e-Pub 2013. PMID: 23290308.
      45. Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 9:45, 2008. e-Pub 2008. PMID: 18498634.

      Invited Articles

      1. Wehner M, Nead KT. Can Google help us fight cancer?. The lancet oncology 19(7):867, 2018. e-Pub 2018. PMID: 30084368.

      Review Articles

      1. Neth BJ, Zhao J, Nead KT. Principles of oncology. J Clin Exp Neuropsychol 47(8):707-731, 2025. e-Pub 2025. PMID: 41311233.
      2. Joo L, Bradley CC, Lin SH, Scheet PA, Nead KT. Causes of Clonal Hematopoiesis: a Review. Curr Oncol Rep 25(3):211-220, 2023. e-Pub 2023. PMID: 36719597.

      Editorials

      1. Neth BJ, Wefel JS, Nead KT. Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations. Transl Androl Urol 14(4):864-867, 2025. PMID: 40376525.
      2. Wasserfall C, Nead K, Mathews C, Atkinson MA. The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes. Diabetologia 54(9):2232-6, 2011. PMID: 21773685.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 17, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Nead Laboratory

      • Epidemiology department

      • Cancer Prevention & Population Sciences division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top